Update on current pharmacologic therapies for diabetic retinopathy.

Sofía M Muns,Victor M Villegas,Harry W Flynn,Stephen G Schwartz

Expert opinion on pharmacotherapy（2023）

引用 0|浏览2

暂无评分

摘要

Emerging anti-VEGF modalities, integrin antagonists, and anti-inflammatory agents have the potential to improve outcomes with reduced treatment burdens.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要